APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Selected research

Market Outlook & Growth Opportunities

Global Artemisinin Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchArtemisinin Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Artemisinin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.

Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

Read the full market overview

In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.

This report provides an overview of the global Artemisinin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artemisinin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artemisinin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemisinin market size, projected growth trends, production technologies, key applications, and end-use industries.

Artemisinin Segment by Company

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

Artemisinin Segment by Type

Extraction From Artemisia Annua

Semisynthetic Artemisinin

Artemisinin Segment by Application

Antimalarial Injections

Antimalarial Tablets

Artemisinin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artemisinin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artemisinin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artemisinin significant trends, drivers, influence factors in global and regions.

6. To analyze Artemisinin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artemisinin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemisinin industry.

Chapter 3: Detailed analysis of Artemisinin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artemisinin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artemisinin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artemisinin Industry Trends Table 2. Artemisinin Industry Drivers Table 3. Artemisinin Industry Opportunities and Challenges Table 4. Artemisinin Industry Restraints Table 5. Global Artemisinin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artemisinin Revenue Share by Company (2021-2026) Table 7. Global Artemisinin Sales Volume by Company (MT) & (2021-2026) Table 8. Global Artemisinin Sales Volume Share by Company (2021-2026) Table 9. Global Artemisinin Average Price (USD/MT) of Company (2021-2026) Table 10. Global Artemisinin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artemisinin Key Company Manufacturing Base & Headquarters Table 12. Global Artemisinin Company, Product Type & Application Table 13. Global Artemisinin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artemisinin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Extraction From Artemisia Annua Table 18. Significant Companies of Semisynthetic Artemisinin Table 19. Global Artemisinin Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Artemisinin Sales Volume by Type (2021-2026) & (MT) Table 21. Global Artemisinin Sales Volume by Type (2027-2032) & (MT) Table 22. Global Artemisinin Sales Volume Share by Type (2021-2026) Table 23. Global Artemisinin Sales Volume Share by Type (2027-2032) Table 24. Global Artemisinin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Artemisinin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Artemisinin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Artemisinin Sales Value Share by Type (2021-2026) Table 28. Global Artemisinin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Antimalarial Injections Table 30. Significant Companies of Antimalarial Tablets Table 31. Global Artemisinin Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global Artemisinin Sales Volume by Application (2021-2026) & (MT) Table 33. Global Artemisinin Sales Volume by Application (2027-2032) & (MT) Table 34. Global Artemisinin Sales Volume Share by Application (2021-2026) Table 35. Global Artemisinin Sales Volume Share by Application (2027-2032) Table 36. Global Artemisinin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Artemisinin Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Artemisinin Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Artemisinin Sales Value Share by Application (2021-2026) Table 40. Global Artemisinin Sales Value Share by Application (2027-2032) Table 41. Global Artemisinin Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 42. Global Artemisinin Sales by Region (2021-2026) & (MT) Table 43. Global Artemisinin Sales Market Share by Region (2021-2026) Table 44. Global Artemisinin Sales by Region (2027-2032) & (MT) Table 45. Global Artemisinin Sales Market Share by Region (2027-2032) Table 46. Global Artemisinin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Artemisinin Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Artemisinin Sales Value Share by Region (2021-2026) Table 49. Global Artemisinin Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Artemisinin Sales Value Share by Region (2027-2032) Table 51. Global Artemisinin Market Average Price (USD/MT) by Region (2021-2026) Table 52. Global Artemisinin Market Average Price (USD/MT) by Region (2027-2032) Table 53. Global Artemisinin Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 54. Global Artemisinin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Artemisinin Sales by Country (2021-2026) & (MT) Table 56. Global Artemisinin Sales Market Share by Country (2021-2026) Table 57. Global Artemisinin Sales by Country (2027-2032) & (MT) Table 58. Global Artemisinin Sales Market Share by Country (2027-2032) Table 59. Global Artemisinin Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Artemisinin Sales Value Market Share by Country (2021-2026) Table 61. Global Artemisinin Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Artemisinin Sales Value Market Share by Country (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 66. Sanofi Artemisinin Product Portfolio Table 67. Sanofi Recent Development Table 68. KPC Pharmaceuticals Company Information Table 69. KPC Pharmaceuticals Business Overview Table 70. KPC Pharmaceuticals Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 71. KPC Pharmaceuticals Artemisinin Product Portfolio Table 72. KPC Pharmaceuticals Recent Development Table 73. Kerui nanhai Company Information Table 74. Kerui nanhai Business Overview Table 75. Kerui nanhai Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 76. Kerui nanhai Artemisinin Product Portfolio Table 77. Kerui nanhai Recent Development Table 78. Guangxi xiancaotang Company Information Table 79. Guangxi xiancaotang Business Overview Table 80. Guangxi xiancaotang Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 81. Guangxi xiancaotang Artemisinin Product Portfolio Table 82. Guangxi xiancaotang Recent Development Table 83. Guilin Pharmaceutical Company Information Table 84. Guilin Pharmaceutical Business Overview Table 85. Guilin Pharmaceutical Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 86. Guilin Pharmaceutical Artemisinin Product Portfolio Table 87. Guilin Pharmaceutical Recent Development Table 88. Natural Bio-engineering Company Information Table 89. Natural Bio-engineering Business Overview Table 90. Natural Bio-engineering Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 91. Natural Bio-engineering Artemisinin Product Portfolio Table 92. Natural Bio-engineering Recent Development Table 93. BIONEXX Company Information Table 94. BIONEXX Business Overview Table 95. BIONEXX Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 96. BIONEXX Artemisinin Product Portfolio Table 97. BIONEXX Recent Development Table 98. CAT KHANH Company Information Table 99. CAT KHANH Business Overview Table 100. CAT KHANH Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 101. CAT KHANH Artemisinin Product Portfolio Table 102. CAT KHANH Recent Development Table 103. BEEPZ Company Information Table 104. BEEPZ Business Overview Table 105. BEEPZ Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 106. BEEPZ Artemisinin Product Portfolio Table 107. BEEPZ Recent Development Table 108. Novanat Bioresource Company Information Table 109. Novanat Bioresource Business Overview Table 110. Novanat Bioresource Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 111. Novanat Bioresource Artemisinin Product Portfolio Table 112. Novanat Bioresource Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Artemisinin Distributors List Table 116. Artemisinin Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Artemisinin Product Image Figure 2. Global Artemisinin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artemisinin Sales (2021-2032) & (MT) Figure 5. Global Artemisinin Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Artemisinin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Extraction From Artemisia Annua Image Figure 10. Semisynthetic Artemisinin Image Figure 11. Global Artemisinin Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Artemisinin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Artemisinin Sales Volume Share by Type (2021-2032) Figure 14. Global Artemisinin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Artemisinin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Artemisinin Sales Value Share by Type (2021-2032) Figure 17. Antimalarial Injections Image Figure 18. Antimalarial Tablets Image Figure 19. Global Artemisinin Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 20. Global Artemisinin Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Artemisinin Sales Volume Share by Application (2021-2032) Figure 22. Global Artemisinin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Artemisinin Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Artemisinin Sales Value Share by Application (2021-2032) Figure 25. Global Artemisinin Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 26. Global Artemisinin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Artemisinin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Artemisinin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Artemisinin Sales Value (2021-2032) & (US$ Million) Figure 30. North America Artemisinin Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Artemisinin Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Artemisinin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Artemisinin Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Artemisinin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Artemisinin Sales Value (2021-2032) & (US$ Million) Figure 36. South America Artemisinin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Artemisinin Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Artemisinin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Artemisinin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Artemisinin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Artemisinin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Artemisinin Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Artemisinin Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Extraction From Artemisia Annua
  • Semisynthetic Artemisinin
Applications
  • Antimalarial Injections
  • Antimalarial Tablets
Companies covered
  • Sanofi
  • KPC Pharmaceuticals
  • Kerui nanhai
  • Guangxi xiancaotang
  • Guilin Pharmaceutical
  • Natural Bio-engineering
  • BIONEXX
  • CAT KHANH
  • BEEPZ
  • Novanat Bioresource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemisinin Sales Value (2021-2032)
  4. 1.2.2 Global Artemisinin Sales Volume (2021-2032)
  5. 1.2.3 Global Artemisinin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artemisinin Market Dynamics
  1. 2.1 Artemisinin Industry Trends
  2. 2.2 Artemisinin Industry Drivers
  3. 2.3 Artemisinin Industry Opportunities and Challenges
  4. 2.4 Artemisinin Industry Restraints
3 Artemisinin Market by Company
  1. 3.1 Global Artemisinin Company Revenue Ranking in 2025
  2. 3.2 Global Artemisinin Revenue by Company (2021-2026)
  3. 3.3 Global Artemisinin Sales Volume by Company (2021-2026)
  4. 3.4 Global Artemisinin Average Price by Company (2021-2026)
  5. 3.5 Global Artemisinin Company Ranking (2024-2026)
  6. 3.6 Global Artemisinin Company Manufacturing Base and Headquarters
  7. 3.7 Global Artemisinin Company Product Type and Application
  8. 3.8 Global Artemisinin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artemisinin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artemisinin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artemisinin Market by Type
  1. 4.1 Artemisinin Type Introduction
  2. 4.1.1 Extraction From Artemisia Annua
  3. 4.1.2 Semisynthetic Artemisinin
  4. 4.2 Global Artemisinin Sales Volume by Type
  5. 4.2.1 Global Artemisinin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artemisinin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Artemisinin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Artemisinin Sales Value by Type
  9. 4.3.1 Global Artemisinin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Artemisinin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Artemisinin Sales Value Share by Type (2021-2032)
5 Artemisinin Market by Application
  1. 5.1 Artemisinin Application Introduction
  2. 5.1.1 Antimalarial Injections
  3. 5.1.2 Antimalarial Tablets
  4. 5.2 Global Artemisinin Sales Volume by Application
  5. 5.2.1 Global Artemisinin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Artemisinin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Artemisinin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Artemisinin Sales Value by Application
  9. 5.3.1 Global Artemisinin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Artemisinin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Artemisinin Sales Value Share by Application (2021-2032)
6 Artemisinin Regional Sales and Value Analysis
  1. 6.1 Global Artemisinin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artemisinin Sales by Region (2021-2032)
  3. 6.2.1 Global Artemisinin Sales by Region: 2021-2026
  4. 6.2.2 Global Artemisinin Sales by Region (2027-2032)
  5. 6.3 Global Artemisinin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artemisinin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artemisinin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artemisinin Sales Value by Region (2027-2032)
  9. 6.5 Global Artemisinin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artemisinin Sales Value (2021-2032)
  12. 6.6.2 North America Artemisinin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artemisinin Sales Value (2021-2032)
  15. 6.7.2 Europe Artemisinin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artemisinin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artemisinin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artemisinin Sales Value (2021-2032)
  21. 6.9.2 South America Artemisinin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artemisinin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artemisinin Sales Value Share by Country, 2025 VS 2032
7 Artemisinin Country-level Sales and Value Analysis
  1. 7.1 Global Artemisinin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artemisinin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artemisinin Sales by Country (2021-2032)
  4. 7.3.1 Global Artemisinin Sales by Country (2021-2026)
  5. 7.3.2 Global Artemisinin Sales by Country (2027-2032)
  6. 7.4 Global Artemisinin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artemisinin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artemisinin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artemisinin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artemisinin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artemisinin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artemisinin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artemisinin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artemisinin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artemisinin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artemisinin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artemisinin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artemisinin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artemisinin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artemisinin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artemisinin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artemisinin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artemisinin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artemisinin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artemisinin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artemisinin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artemisinin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artemisinin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artemisinin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artemisinin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artemisinin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artemisinin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artemisinin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artemisinin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artemisinin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artemisinin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artemisinin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artemisinin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artemisinin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artemisinin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artemisinin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artemisinin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artemisinin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artemisinin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artemisinin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artemisinin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artemisinin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artemisinin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artemisinin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artemisinin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artemisinin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artemisinin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artemisinin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artemisinin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artemisinin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artemisinin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artemisinin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artemisinin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artemisinin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artemisinin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artemisinin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artemisinin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artemisinin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artemisinin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artemisinin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artemisinin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artemisinin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artemisinin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artemisinin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artemisinin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artemisinin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artemisinin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artemisinin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artemisinin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artemisinin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artemisinin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artemisinin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artemisinin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artemisinin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artemisinin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artemisinin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artemisinin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artemisinin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artemisinin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artemisinin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artemisinin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artemisinin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artemisinin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artemisinin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artemisinin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artemisinin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artemisinin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Artemisinin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Artemisinin Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 KPC Pharmaceuticals
  8. 8.2.1 KPC Pharmaceuticals Company Information
  9. 8.2.2 KPC Pharmaceuticals Business Overview
  10. 8.2.3 KPC Pharmaceuticals Artemisinin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 KPC Pharmaceuticals Artemisinin Product Portfolio
  12. 8.2.5 KPC Pharmaceuticals Recent Developments
  13. 8.3 Kerui nanhai
  14. 8.3.1 Kerui nanhai Company Information
  15. 8.3.2 Kerui nanhai Business Overview
  16. 8.3.3 Kerui nanhai Artemisinin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kerui nanhai Artemisinin Product Portfolio
  18. 8.3.5 Kerui nanhai Recent Developments
  19. 8.4 Guangxi xiancaotang
  20. 8.4.1 Guangxi xiancaotang Company Information
  21. 8.4.2 Guangxi xiancaotang Business Overview
  22. 8.4.3 Guangxi xiancaotang Artemisinin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guangxi xiancaotang Artemisinin Product Portfolio
  24. 8.4.5 Guangxi xiancaotang Recent Developments
  25. 8.5 Guilin Pharmaceutical
  26. 8.5.1 Guilin Pharmaceutical Company Information
  27. 8.5.2 Guilin Pharmaceutical Business Overview
  28. 8.5.3 Guilin Pharmaceutical Artemisinin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guilin Pharmaceutical Artemisinin Product Portfolio
  30. 8.5.5 Guilin Pharmaceutical Recent Developments
  31. 8.6 Natural Bio-engineering
  32. 8.6.1 Natural Bio-engineering Company Information
  33. 8.6.2 Natural Bio-engineering Business Overview
  34. 8.6.3 Natural Bio-engineering Artemisinin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Natural Bio-engineering Artemisinin Product Portfolio
  36. 8.6.5 Natural Bio-engineering Recent Developments
  37. 8.7 BIONEXX
  38. 8.7.1 BIONEXX Company Information
  39. 8.7.2 BIONEXX Business Overview
  40. 8.7.3 BIONEXX Artemisinin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BIONEXX Artemisinin Product Portfolio
  42. 8.7.5 BIONEXX Recent Developments
  43. 8.8 CAT KHANH
  44. 8.8.1 CAT KHANH Company Information
  45. 8.8.2 CAT KHANH Business Overview
  46. 8.8.3 CAT KHANH Artemisinin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CAT KHANH Artemisinin Product Portfolio
  48. 8.8.5 CAT KHANH Recent Developments
  49. 8.9 BEEPZ
  50. 8.9.1 BEEPZ Company Information
  51. 8.9.2 BEEPZ Business Overview
  52. 8.9.3 BEEPZ Artemisinin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BEEPZ Artemisinin Product Portfolio
  54. 8.9.5 BEEPZ Recent Developments
  55. 8.10 Novanat Bioresource
  56. 8.10.1 Novanat Bioresource Company Information
  57. 8.10.2 Novanat Bioresource Business Overview
  58. 8.10.3 Novanat Bioresource Artemisinin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novanat Bioresource Artemisinin Product Portfolio
  60. 8.10.5 Novanat Bioresource Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artemisinin Value Chain Analysis
  2. 9.1.1 Artemisinin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artemisinin Sales Mode & Process
  6. 9.2 Artemisinin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artemisinin Distributors
  9. 9.2.3 Artemisinin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst